Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zhuotai Zhong"'
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract More than 80% of patients with myasthenia gravis (MG) are positive for anti-acetylcholine receptor (AChR) antibodies. Regulatory T cells (Tregs) suppress overproduction of these antibodies, and patients with AChR antibody-positive MG (AChR M
Externí odkaz:
https://doaj.org/article/a21b219506104429b8b717a56281817c
Autor:
Xueping Zhang, Lei Chen, Tao Zhang, Ryu Gabo, Qianying Wang, Zhuotai Zhong, Mengxi Yao, Wei Wei, Xiaolan Su
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Background and aimsFunctional dyspepsia (FD) is a common gastrointestinal disorder associated with brain–gut interaction disturbances. In recent years, accumulating evidence points to the duodenum as a key integrator in dyspepsia symptom generation
Externí odkaz:
https://doaj.org/article/5ab953f052744f33816dcc8ab76bd385
Autor:
Lin Wang, Xiaoying Luo, Xiangli Qing, Shuangshuang Fang, Tianyuan Jiang, Qianying Wang, Zhuotai Zhong, Yang Yang, Jianqin Yang, Gengqing Song, Xiaolan Su, Wei Wei
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Functional gastrointestinal disorders (FGIDs) are closely related to disorders of brain-gut interaction. FGIDs are the dominant disease of acupuncture treatment, which can improve the symptoms and emotional state. Aim To evaluate
Externí odkaz:
https://doaj.org/article/ac3efa677eb44ab9bf7a97be810fb25a
Autor:
Senhui Weng, Linwen Huang, Bingxing Cai, Long He, Shuting Wen, Jinghao Li, Zhuotai Zhong, Haiyan Zhang, Chongyang Huang, Yunying Yang, Qilong Jiang, Fengbin Liu
Publikováno v:
Chinese Medicine, Vol 18, Iss 1, Pp 1-18 (2023)
Abstract Background Myasthenia gravis (MG) is an antibody-mediated autoimmune disease and its pathogenesis is closely related to CD4 + T cells. In recent years, gut microbiota is considered to play an important role in the pathogenesis of MG. Astraga
Externí odkaz:
https://doaj.org/article/a899d93a345440069221cf7a82f49b1e
Autor:
Senhui Weng, Jinghao Li, Benshu Chen, Long He, Zhuotai Zhong, Linwen Huang, Shijing Zhang, Fengbin Liu, Qilong Jiang
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Myasthenia gravis (MG) is an acquired autoimmune disease with high heterogeneity. The disease is chronic, relapsing repeatedly and progressive with acute exacerbation occasionally. Although the treatment of MG has developed, it is
Externí odkaz:
https://doaj.org/article/d096713199a442bc8b1c135e83f676f4
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with gut microbiota disequilibrium and regulatory T (Treg)/T helper 17 (Th17) immune imbalance. Stigmasterol, a plant-derived sterol, has shown anti-inflammatory effects. Our study a
Externí odkaz:
https://doaj.org/article/d4da9c9faa11464db1689b72993c474e
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The drug 5-aminosalicylic acid (5-ASA) is the first-line therapy for the treatment of patients with mild-to-moderate ulcerative colitis (UC). However, in some cases, 5-ASA cannot achieve the desired therapeutic effects. Therefore, patient
Externí odkaz:
https://doaj.org/article/b1854a69d03e4544ab077a6c4af42af5
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
BackgroundColorectal cancer (CRC) is a common malignant tumor of the digestive tract with a high mortality rate. Growing evidence demonstrates that immune-related genes play a prominent role in the occurrence and development of CRC. The aim of this s
Externí odkaz:
https://doaj.org/article/4a89697954bb4b33b4bc4c0ab9abd1e1
Publikováno v:
Journal of Ethnopharmacology. 314:116621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53c78ff413a3fc972628d00e327ffa4e
https://doi.org/10.1016/j.jep.2023.116621
https://doi.org/10.1016/j.jep.2023.116621
Autor:
Fengbin Liu, Senhui Weng, Zhuotai Zhong, Qilong Jiang, Jinghao Li, Linwen Huang, Benshu Chen, Long He
Background: Myasthenia gravis (MG) is an acquired autoimmune disease with high heterogeneity. The disease is chronic, relapsing repeatedly and progressive with acute exacerbation occasionally. Although the treatment of MG has developed, it is still u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af98c9dac8a0f3f3e8dc0fc7a77f6df1
https://doi.org/10.21203/rs.3.rs-669706/v1
https://doi.org/10.21203/rs.3.rs-669706/v1
